1 reports of this reaction
16.7% of all METHYL SALICYLATE, MENTHOL reports
#4 most reported adverse reaction
BREAST PAIN is the #4 most commonly reported adverse reaction for METHYL SALICYLATE, MENTHOL, manufactured by Accord Healthcare, Inc.. There are 1 FDA adverse event reports linking METHYL SALICYLATE, MENTHOL to BREAST PAIN. This represents approximately 16.7% of all 6 adverse event reports for this drug.
Patients taking METHYL SALICYLATE, MENTHOL who experience breast pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BREAST PAIN is a frequently reported adverse event for METHYL SALICYLATE, MENTHOL, accounting for a significant proportion of all reports.
In addition to breast pain, the following adverse reactions have been reported for METHYL SALICYLATE, MENTHOL:
The following drugs have also been linked to breast pain in FDA adverse event reports:
BREAST PAIN has been reported as an adverse event in 1 FDA reports for METHYL SALICYLATE, MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
BREAST PAIN accounts for approximately 16.7% of all adverse event reports for METHYL SALICYLATE, MENTHOL, making it a notable side effect.
If you experience breast pain while taking METHYL SALICYLATE, MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.